22-gauge ProCore Needle v. Standard 22-gauge (P00030500)



Status:Completed
Healthy:No
Age Range:18 - Any
Updated:5/2/2018
Start Date:June 2014
End Date:December 19, 2017

Use our guide to learn which trials are right for you!

A Multi-center Study Comparing Standard 22-gauge and 22-gauge ProCore Needles for Endobronchial Ultrasound

The purpose of this study is to compare the usefulness of two needles (used for obtaining a
lung tissue sample : (1) standard 22-gauge, and (2) ProCore 22-gauge) for endobronchial
ultrasound

The purpose of this study is to compare the usefulness of two needles used for obtaining a
lung tissue sample: (1) standard 22-gauge, and (2) ProCore 22-gauge. Both of these needles
are used to get biopsies (samples) of lung tissue. The standard needle has one bevel (angled
side of the needle formed when it is sharpened to make a point), while the ProCore needle has
2 bevels. The standard needle is more commonly used and we are doing this study to see if the
ProCore needle would be more useful.

The investigator in charge of this study is Dr. Nichole T. Tanner. This study is being done
at four sites and will involve approximately 200 volunteers.

Inclusion Criteria:

1. Subjects with known or suspected lung cancer with mediastinal adenopathy as defined by
a mediastinal lymph node >1 cm in short axis or a normal sized lymph node with uptake
on FDG-PET scan that is higher than background PET activity.

2. Participants must be at least 18 years old or older, lack bleeding disorders, and be
able to provide informed consent. The latter two criteria will be assessed from the
patient's history and the consenting interview.

Exclusion Criteria:

1. Subjects who refuse to participate, or demonstrate inability to give informed consent

2. Subjects who are less than 18 years of age

3. Subjects who lack fitness for flexible bronchoscopy as determined by the physician
performing the bronchoscopy before the procedure

4. Subjects with suspected sarcoidosis, lymphoma, or metastatic cancer from other sites
(i.e. those without a known or suspected lung primary)

5. Subjects on anticoagulation (other than Aspirin) whom cannot have their
anticoagulation held for the procedure due to other clinical reasons (i.e. recent
cardiac stent placement).
We found this trial at
4
sites
3400 N Charles St
Baltimore, Maryland 21205
410-516-8000
Principal Investigator: Lonny Yarmus
Phone: 410-955-5288
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gainesville, Florida 32610
(352) 392-3261
Principal Investigator: Hiren Hiren, MD
University of Florida The University of Florida (UF) is a major, public, comprehensive, land-grant, research...
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Chapel Hill, North Carolina
Principal Investigator: Jason Akulian
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: Nichole T Tanner, MD, M.S.C.R
Phone: 843-792-4557
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials